
Ziaul Karim
Examiner (ID: 14835, Phone: (571)270-3279 , Office: P/2127 )
| Most Active Art Unit | 2119 |
| Art Unit(s) | 2127, 2119 |
| Total Applications | 971 |
| Issued Applications | 802 |
| Pending Applications | 63 |
| Abandoned Applications | 133 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20438670
[patent_doc_number] => 12509497
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-30
[patent_title] => Relaxin-2 fusion protein analogs and methods of using same
[patent_app_type] => utility
[patent_app_number] => 18/054596
[patent_app_country] => US
[patent_app_date] => 2022-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18234
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18054596
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/054596 | Relaxin-2 fusion protein analogs and methods of using same | Nov 10, 2022 | Issued |
Array
(
[id] => 18582869
[patent_doc_number] => 20230265126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => UBIQUITIN HIGH AFFINITY CYCLIC PEPTIDES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/982883
[patent_app_country] => US
[patent_app_date] => 2022-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17982883
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/982883 | Ubiquitin high affinity cyclic peptides and methods of use thereof | Nov 7, 2022 | Issued |
Array
(
[id] => 18626786
[patent_doc_number] => 20230285594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => COMPLEXATION OF NUCLEIC ACIDS WITH DISULFIDE-CROSSLINKED CATIONIC COMPONENTS FOR TRANSFECTION AND IMMUNOSTIMULATION
[patent_app_type] => utility
[patent_app_number] => 18/052529
[patent_app_country] => US
[patent_app_date] => 2022-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40779
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18052529
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/052529 | COMPLEXATION OF NUCLEIC ACIDS WITH DISULFIDE-CROSSLINKED CATIONIC COMPONENTS FOR TRANSFECTION AND IMMUNOSTIMULATION | Nov 2, 2022 | Abandoned |
Array
(
[id] => 19969684
[patent_doc_number] => 12338276
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-24
[patent_title] => Fibronectin type III domain-based protein and application thereof
[patent_app_type] => utility
[patent_app_number] => 17/977247
[patent_app_country] => US
[patent_app_date] => 2022-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 8496
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 618
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17977247
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/977247 | Fibronectin type III domain-based protein and application thereof | Oct 30, 2022 | Issued |
Array
(
[id] => 18451523
[patent_doc_number] => 20230192801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => NOVEL INSULIN ANALOGUES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/961438
[patent_app_country] => US
[patent_app_date] => 2022-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16579
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17961438
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/961438 | Insulin analogues and uses thereof | Oct 5, 2022 | Issued |
Array
(
[id] => 18294804
[patent_doc_number] => 20230104490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => High-activity memory-improving derivative peptide and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/936424
[patent_app_country] => US
[patent_app_date] => 2022-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5644
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17936424
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/936424 | High-activity memory-improving derivative peptide and use thereof | Sep 28, 2022 | Issued |
Array
(
[id] => 19411803
[patent_doc_number] => 12077610
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-03
[patent_title] => Peptides and other agents for treating pain and increasing pain sensitivity
[patent_app_type] => utility
[patent_app_number] => 17/956031
[patent_app_country] => US
[patent_app_date] => 2022-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 16
[patent_no_of_words] => 16078
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17956031
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/956031 | Peptides and other agents for treating pain and increasing pain sensitivity | Sep 28, 2022 | Issued |
Array
(
[id] => 19731121
[patent_doc_number] => 12209112
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-28
[patent_title] => Methods of preventing or treating diseases, conditions, or disorders associated with chemotherapy
[patent_app_type] => utility
[patent_app_number] => 17/932302
[patent_app_country] => US
[patent_app_date] => 2022-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 51
[patent_no_of_words] => 11435
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17932302
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/932302 | Methods of preventing or treating diseases, conditions, or disorders associated with chemotherapy | Sep 14, 2022 | Issued |
Array
(
[id] => 20437500
[patent_doc_number] => 12508322
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-30
[patent_title] => MIR-145 micelles for mitigating atherosclerosis
[patent_app_type] => utility
[patent_app_number] => 17/940460
[patent_app_country] => US
[patent_app_date] => 2022-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 76
[patent_no_of_words] => 11531
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17940460
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/940460 | MIR-145 micelles for mitigating atherosclerosis | Sep 7, 2022 | Issued |
Array
(
[id] => 19076498
[patent_doc_number] => 11945848
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-02
[patent_title] => Chimeric inhibitor molecules of complement activation
[patent_app_type] => utility
[patent_app_number] => 17/818583
[patent_app_country] => US
[patent_app_date] => 2022-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 39
[patent_no_of_words] => 36934
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 197
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17818583
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/818583 | Chimeric inhibitor molecules of complement activation | Aug 8, 2022 | Issued |
Array
(
[id] => 18211530
[patent_doc_number] => 20230057793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => ARC-BASED CAPSIDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/818318
[patent_app_country] => US
[patent_app_date] => 2022-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17818318
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/818318 | ARC-BASED CAPSIDS AND USES THEREOF | Aug 7, 2022 | Abandoned |
Array
(
[id] => 19762170
[patent_doc_number] => 12220440
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-11
[patent_title] => Drug composition, method for treating infection, disinfecting composition, and drug adjuvant
[patent_app_type] => utility
[patent_app_number] => 17/862617
[patent_app_country] => US
[patent_app_date] => 2022-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 16
[patent_no_of_words] => 6420
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17862617
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/862617 | Drug composition, method for treating infection, disinfecting composition, and drug adjuvant | Jul 11, 2022 | Issued |
Array
(
[id] => 18620431
[patent_doc_number] => 11753459
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => Anti-VEGF protein compositions and methods for producing the same
[patent_app_type] => utility
[patent_app_number] => 17/858724
[patent_app_country] => US
[patent_app_date] => 2022-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 86
[patent_no_of_words] => 67490
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17858724
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/858724 | Anti-VEGF protein compositions and methods for producing the same | Jul 5, 2022 | Issued |
Array
(
[id] => 18194681
[patent_doc_number] => 20230048200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/854986
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30286
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17854986
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/854986 | Collagen peptide-based medicament compositions and devices and methods of production and use thereof | Jun 29, 2022 | Issued |
Array
(
[id] => 18418624
[patent_doc_number] => 20230173082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => ANTIBACTERIAL PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 17/855222
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16587
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17855222
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/855222 | ANTIBACTERIAL PRODUCTS | Jun 29, 2022 | Pending |
Array
(
[id] => 18182857
[patent_doc_number] => 20230043587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/846686
[patent_app_country] => US
[patent_app_date] => 2022-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22830
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17846686
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/846686 | Methods and compositions for the prevention and treatment of disease | Jun 21, 2022 | Issued |
Array
(
[id] => 18102442
[patent_doc_number] => 11542317
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-01-03
[patent_title] => Anti-VEGF protein compositions and methods for producing the same
[patent_app_type] => utility
[patent_app_number] => 17/842286
[patent_app_country] => US
[patent_app_date] => 2022-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 86
[patent_no_of_words] => 68064
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17842286
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/842286 | Anti-VEGF protein compositions and methods for producing the same | Jun 15, 2022 | Issued |
Array
(
[id] => 19563541
[patent_doc_number] => 12138292
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-12
[patent_title] => Compounds and therapeutics uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/839026
[patent_app_country] => US
[patent_app_date] => 2022-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 2
[patent_no_of_words] => 14284
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 432
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17839026
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/839026 | Compounds and therapeutics uses thereof | Jun 12, 2022 | Issued |
Array
(
[id] => 19897854
[patent_doc_number] => 12275760
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-15
[patent_title] => Amino acid-specific binder and selectively identifying an amino acid
[patent_app_type] => utility
[patent_app_number] => 17/837082
[patent_app_country] => US
[patent_app_date] => 2022-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 13110
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17837082
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/837082 | Amino acid-specific binder and selectively identifying an amino acid | Jun 9, 2022 | Issued |
Array
(
[id] => 18777862
[patent_doc_number] => 11819538
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-11-21
[patent_title] => Collagen daily with enzyme inhibitors for anti-aging
[patent_app_type] => utility
[patent_app_number] => 17/835689
[patent_app_country] => US
[patent_app_date] => 2022-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1825
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17835689
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/835689 | Collagen daily with enzyme inhibitors for anti-aging | Jun 7, 2022 | Issued |